BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 2653057)

  • 21. Treatment of alcohol withdrawal syndrome with a combination of tiapride/carbamazepine: results of a pooled analysis in 540 patients.
    Soyka M; Schmidt P; Franz M; Barth T; de Groot M; Kienast T; Reinert T; Richter C; Sander G
    Eur Arch Psychiatry Clin Neurosci; 2006 Oct; 256(7):395-401. PubMed ID: 16917685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial.
    Malcolm R; Myrick H; Roberts J; Wang W; Anton RF; Ballenger JC
    J Gen Intern Med; 2002 May; 17(5):349-55. PubMed ID: 12047731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
    Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal.
    Mayo-Smith MF
    JAMA; 1997 Jul; 278(2):144-51. PubMed ID: 9214531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of outpatient alcohol detoxification with a combination of tiapride/carbamazepine: additional evidence.
    Soyka M; Schmidt F; Schmidt P
    Pharmacopsychiatry; 2006 Jan; 39(1):30-4. PubMed ID: 16453252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium oxybate in the treatment of alcohol withdrawal syndrome: a randomized double-blind comparative study versus oxazepam. The GATE 1 trial.
    Caputo F; Skala K; Mirijello A; Ferrulli A; Walter H; Lesch O; Addolorato G
    CNS Drugs; 2014 Aug; 28(8):743-52. PubMed ID: 24996524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled comparison of buspirone and oxazepam in generalized anxiety.
    Ansseau M; Papart P; Gérard MA; von Frenckell R; Franck G
    Neuropsychobiology; 1990-1991; 24(2):74-8. PubMed ID: 2134114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxcarbazepine versus carbamazepine in the treatment of alcohol withdrawal.
    Schik G; Wedegaertner FR; Liersch J; Hoy L; Emrich HM; Schneider U
    Addict Biol; 2005 Sep; 10(3):283-8. PubMed ID: 16109591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physostigmine in eyedrops decreases craving for alcohol in early withdrawal treated with carbamazepine.
    Stojek A; Napierała K
    Mater Med Pol; 1986; 18(4):249-54. PubMed ID: 3613684
    [No Abstract]   [Full Text] [Related]  

  • 30. Atenolol for alcohol withdrawal.
    N Engl J Med; 1986 Mar; 314(12):782-4. PubMed ID: 3513013
    [No Abstract]   [Full Text] [Related]  

  • 31. [Acute benzodiazepine withdrawal delirium].
    Mäkinen VN; Hansen KB; Knudsen ST
    Ugeskr Laeger; 2022 Jun; 184(23):. PubMed ID: 35703059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alcohol withdrawal--biological background, diagnosis and treatment].
    Johnsen J; Mørland J
    Tidsskr Nor Laegeforen; 1990 May; 110(12):1528-32. PubMed ID: 1971124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial.
    Melby K; Gråwe RW; Aamo TO; Salvesen Ø; Spigset O
    Drug Alcohol Depend; 2019 Apr; 197():95-101. PubMed ID: 30784955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized clinical trial of atenolol in patients with alcohol withdrawal.
    Kraus ML; Gottlieb LD; Horwitz RI; Anscher M
    N Engl J Med; 1985 Oct; 313(15):905-9. PubMed ID: 2863754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association carbamazepine-mianserin in opiate withdrawal: a double blind pilot study versus clonidine.
    Bertschy G; Bryois C; Bondolfi G; Velardi A; Budry P; Dascal D; Martinet C; Baettig D; Baumann P
    Pharmacol Res; 1997 May; 35(5):451-6. PubMed ID: 9308074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, controlled trial in primary care patients with generalized anxiety: a comparison between buspirone and oxazepam.
    Strand M; Hetta J; Rosen A; Sörensen S; Malmström R; Fabian C; Marits K; Vetterskog K; Liljestrand AG; Hegen C
    J Clin Psychiatry; 1990 Sep; 51 Suppl():40-5. PubMed ID: 2211567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid.
    Hillbom M; Tokola R; Kuusela V; Kärkkäinen P; Källi-Lemma L; Pilke A; Kaste M
    Alcohol; 1989; 6(3):223-6. PubMed ID: 2500138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The prophylaxis of benzodiazepine withdrawal syndrome in the elderly: the effectiveness of carbamazepine. Double-blind study vs. placebo].
    Di Costanzo E; Rovea A
    Minerva Psichiatr; 1992; 33(4):301-4. PubMed ID: 1297907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late-onset seizures in alcohol withdrawal.
    Mayo-Smith MF; Bernard D
    Alcohol Clin Exp Res; 1995 Jun; 19(3):656-9. PubMed ID: 7573789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of alcoholic withdrawal syndromes with carbamazepine].
    Lier A; Lier G
    Med Welt; 1979 Oct; 30(43):1612-4. PubMed ID: 514042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.